BIRC5 and neoplasm: The expression of tumor-associated antigens, such as survivin and PBF, in a patient with MFS positive for HLA class-I, was exploited by peptide vaccination therapy using PBF and survivin peptides in incomplete Freund’s adjuvant, and PEG-conjugated interferon-α.